28 Jul 2014 --- A new bidder has reportedly emerged for Danone’s medical nutrition arm, in a deal that is believed to be worth $5bn. At present talks are thought to be taking place between Danone and US pharmaceutical firm Hospira, and a potential cash and stock deal is thought to form the basis of the discussions.
